Content about Gardasil

November 15, 2013

An experimental human papillomavirus vaccine made by Merck could offer a boost to the vaccine market, but the company will have to use effective marketing efforts to ensure uptake, according to a new study.

LONDON — An experimental human papillomavirus vaccine made by Merck could offer a boost to the vaccine market, but the company will have to use effective marketing efforts to ensure uptake, according to a new study.

The London-based research and consulting firm GlobalData said Merck's V503 vaccine, currently in phase-3 clinical trials, had strong potential because it protects against five HPV types not covered by current vaccines and demonstrates 97% efficacy against precancerous lesions caused by the additional virus types it contains.

July 26, 2013

While rates of human papillomavirus infection among girls ages 14 years to 19 years have dropped by half since the Centers for Disease Control and Prevention started recommending routine vaccination against it seven years ago, rates of vaccination have not increased, the agency said.

ATLANTA — While rates of human papillomavirus infection among girls ages 14 years to 19 years have dropped by half since the Centers for Disease Control and Prevention started recommending routine vaccination against it seven years ago, rates of vaccination have not increased, the agency said.

According to the CDC's Morbidity and Mortality Weekly Report, HPV vaccination coverage for girls did not increase over last year. The survey included vaccination records of about 19,000 teenagers.

March 28, 2012

As pharmacies become increasingly involved in flu shots, retail-based clinics are expanding into other areas of vaccination — such as vaccines to help protect against human papillomavirus, meningitis and pneumonia — to further meet the healthcare needs of patients.

As pharmacies become increasingly involved in flu shots, retail-based clinics are expanding into other areas of vaccination — such as vaccines to help protect against human papillomavirus, meningitis and pneumonia — to further meet the healthcare needs of patients.

January 25, 2012

A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.

PASADENA, Calif. — A human papillomavirus vaccine created by drug maker Merck does not cause autoimmune conditions after young women are inoculated, according to a new Kaiser Permanente study.

October 25, 2011

An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.

ATLANTA — An advisory committee of the Centers for Disease Control and Prevention is recommending that all boys ages 11 and 12 years old get vaccinated against human papillomavirus, the CDC said Tuesday.

The agency said the Advisory Committee on Immunization Practices voted for recommending routine vaccination of boys with three doses of HPV4 to protect against the virus. The vaccination is able to prevent such HPV-related conditions as cancer and prevent the spread of the virus to sexual partners. The recommendation is still subject to the CDC's approval, the agency said.

October 11, 2011

At the beginning of the year, a major global controversy was settled when it turned out that a study published in The Lancet in 1998 linking the measles-mumps-rubella vaccine to autism in children turned out to be a whopper of a fraud.


At the beginning of the year, a major global controversy was settled when it turned out that a study published in The Lancet in 1998 linking the measles-mumps-rubella vaccine to autism in children turned out to be a whopper of a fraud.


But despite the exposure of the study’s author — and outbreaks of preventable diseases among children in the United States and Europe, thanks to parents who opted to have their kids vaccinated — it appears that sowing fear of childhood vaccines still appears to have some currency.


September 20, 2011

Health experts have expressed fear that Republican presidential candidate Michele Bachmann's comments about the human papillomavirus vaccine could set back progress in vaccinations, according to published reports.

NEW YORK — Health experts have expressed fear that Republican presidential candidate Michele Bachmann's comments about the human papillomavirus vaccine could set back progress in vaccinations, according to published reports.

The New York Times quoted experts as saying that vaccination rates often drop when public figures raise alarms about vaccines, including one who said it could set back efforts to vaccinate against human papillomavirus — a sexually transmitted infection that causes genital warts and several cancers in men and women — by three years.

September 14, 2011

Attacks on a human papillomavirus vaccine made amid an increasingly caustic Republican presidential primary battle have drawn a response from the manufacturer.

NEW YORK — Attacks on a human papillomavirus vaccine made amid an increasingly caustic Republican presidential primary battle have drawn a response from the manufacturer.

April 25, 2011

CVS Caremark's MinuteClinic division has expanded its suite of services to now include vitamin B12 injections and the human papillomavirus vaccination Gardasil.

WOONSOCKET, R.I. — CVS Caremark's MinuteClinic division has expanded its suite of services to now include vitamin B12 injections and the human papillomavirus vaccination Gardasil.

February 10, 2011

Take Care Health Systems announced Thursday that through April 30, the retail clinic operator will be offering sports and camp physicals for $35. The physicals, regularly $60, are administered by board-certified nurse practitioners and physician assistants at select Walgreens locations.

CONSHOHOCKEN, Pa. — Take Care Health Systems announced Thursday that through April 30, the retail clinic operator will be offering sports and camp physicals for $35. The physicals, regularly $60, are administered by board-certified nurse practitioners and physician assistants at select Walgreens locations.

February 3, 2011

Merck’s vaccine for human papillomavirus is 89% effective in preventing genital warts in teenage boys and young men, according to a new study.

WHITEHOUSE STATION, N.J. — Merck’s vaccine for human papillomavirus is 89% effective in preventing genital warts in teenage boys and young men, according to a new study.

The phase-3 study of Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant) in boys and men ages 16 to 26 years was published in the Feb. 3 issue of the New England Journal of Medicine. Human papillomavirus is the cause of genital and anal warts, and infection can increase the risk of developing cancer later in life.

December 23, 2010

Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

WHITEHOUSE STATION, N.J. — Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

According to the company, Gardasil is the first HPV vaccine on the market available for use in both men and women, and the only one indicated  to help prevent cervical, vaginal, vulvar and anal cancers and pre-cancers, as well as genital warts, caused by certain types of HPV.

November 16, 2010

A Food and Drug Administration advisory committee has recommended expanded approval of a vaccine for...

WHITEHOUSE STATION, N.J. — A Food and Drug Administration advisory committee has recommended expanded approval of a vaccine for genital warts.

Merck announced Wednesday that the FDA Vaccines and Related Biological Products Advisory Committee recommended approval of Gardasil (human papillomavirus quadrivalent [types 6, 11, 16 and 18] vaccine, recombinant) for males and females ages 9 to 26 years to prevent anal cancer and anal intraepithelial neoplasia, both diseases that result from infection by the human papillomavirus.

February 17, 2010

A vaccine made by Merck for preventing human papillomavirus works for preventing anal warts and...